טוען...
Rationalized design of a mucosal vaccine protects against Mycobacterium tuberculosis challenge in mice
Pulmonary tuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) is a leading cause of global morbidity and mortality. The only licensed TB vaccine, Mycobacterium bovis bacillus Calmette-Guerin (BCG), has variable efficacy in protecting against pulmonary TB. Thus, the development of more effec...
שמור ב:
| הוצא לאור ב: | J Leukoc Biol |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Society for Leukocyte Biology
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5433857/ https://ncbi.nlm.nih.gov/pubmed/28258153 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1189/jlb.4A0616-270R |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|